Azenta(US:AZTA) Prnewswire·2025-11-21 11:30Core Viewpoint - Azenta, Inc. reported a transformative fiscal year 2025 with significant revenue growth and margin expansion, positioning the company for continued growth in fiscal 2026 [3][5]. Financial Performance - For Q4 2025, revenue from continuing operations was $159 million, a 6% increase year-over-year, with organic growth of 4% [2][6]. - Full year revenue for fiscal 2025 reached $594 million, up 4% year-over-year, with organic revenue growth of 3% [2][6]. - Adjusted EBITDA for Q4 2025 was $21 million, representing a 29% increase from the previous year, with an adjusted EBITDA margin of 13.0% [2][6]. - The company achieved a diluted EPS from continuing operations of $1.11 for Q4 2025, compared to a loss of $0.04 in the same quarter last year [2][6]. Segment Performance - Sample Management Solutions generated $86 million in revenue for Q4 2025, a 2% increase year-over-year, while Multiomics revenue was $73 million, up 11% year-over-year [2][6]. - For the full year, Sample Management Solutions revenue was $325 million, a 2% increase, and Multiomics revenue was $269 million, up 6% year-over-year [2][6]. Management Insights - The CEO highlighted the company's streamlined structure and focus on customer needs, projecting core growth of 3% to 5% and approximately 300 basis points of adjusted EBITDA margin expansion for fiscal 2026 [3][5]. - The company emphasized improvements in quality, delivery, and productivity as key drivers of its recent success [3]. Cash and Liquidity - As of September 30, 2025, Azenta had a total balance of cash, cash equivalents, restricted cash, and marketable securities amounting to $546 million [2][6]. Guidance - Azenta expects organic revenue growth for fiscal 2026 to be in the range of 3% to 5%, along with an anticipated adjusted EBITDA margin expansion of approximately 300 basis points [5][6].